<?xml version="1.0" encoding="ISO-8859-1"?>
<!DOCTYPE words SYSTEM "markables.dtd">
<markables xmlns="www.eml.org/NameSpaces/parse">
<markable id="markable_10001" span="word_1..word_27" tag="(S1 (S (NP (CD Two) (JJ Japanese) (NNS scientists)) (VP (VBD said) (SBAR (S (NP (PRP they)) (VP (VBD discovered) (NP (NP (DT an) (NN antibody)) (SBAR (WHNP (WDT that)) (S (, ,) (PP (IN in) (NP (NN laboratory) (NML (NN test) (HYPH -) (NN tube)) (NNS experiments))) (, ,) (VP (VBZ kills) (NP (ADJP (NNP AIDS) (HYPH -) (VBN infected)) (NNS cells)))))) (SBAR (IN while) (S (VP (VBG preserving) (NP (JJ healthy) (NNS cells))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10002" span="word_28..word_48" tag="(S1 (S (SBAR (IN If) (S (NP (JJ further) (NNS experiments)) (VP (VBP are) (ADJP (JJ successful))))) (, ,) (NP (DT the) (NN work)) (VP (MD would) (VP (VB represent) (NP (NP (DT a) (JJ major) (NN advance)) (PP (IN in) (NP (NP (NN research)) (PP (IN on) (NP (NML (VBN acquired) (JJ immune) (NN deficiency)) (NN syndrome)))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10003" span="word_49..word_75" tag="(S1 (S (NP (NP (DT The) (NN drug) (NNP AZT)) (, ,) (NP (NP (DT the) (JJ only) (NN treatment)) (PP (ADVP (RB currently)) (IN on) (NP (DT the) (NN market)))) (, ,)) (VP (VBZ claims) (S (ADVP (RB only)) (VP (VP (TO to) (VP (VB help) (S (VP (VB stop) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (NNP AIDS)))))))) (, ,) (RB not) (VP (TO to) (VP (VB cure) (NP (PRP it))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10004" span="word_76..word_105" tag="(S1 (S (CC But) (NP (NP (NP (JJ several) (NNS analysts)) (CC and) (NP (JJ Japanese) (NNS scientists))) (ADJP (JJ familiar) (PP (IN with) (NP (NP (DT the) (NN study)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN announced) (PP (IN at) (NP (NP (DT a) (NN conference)) (PP (IN in) (NP (NNP Nagoya))))) (NP (NN yesterday)))))) (, ,))))) (VP (VBD expressed) (NP (NP (NN skepticism)) (PP (IN over) (NP (NP (DT the) (NN significance)) (PP (IN of) (NP (DT the) (NNS results))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10005" span="word_106..word_129" tag="(S1 (S (CC And) (NP (DT the) (NNS researchers)) (ADVP (PRP themselves)) (VP (VBD acknowledged) (SBAR (S (NP (PRP they)) (ADVP (RB still)) (VP (MD must) (VP (VB do) (NP (ADJP (RB much) (JJR more)) (NN work)) (SBAR (IN before) (S (NP (PRP they)) (VP (MD can) (VP (VB say) (SBAR (IN whether) (S (NP (DT the) (NN treatment)) (VP (MD would) (ADVP (RB actually)) (VP (VB cure) (NP (NNS humans))))))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10006" span="word_130..word_168" tag="(S1 (S (NP (NP (NNP Shin) (NNP Yonehara)) (, ,) (NP (NP (DT a) (NN research) (NN scientist)) (PP (IN at) (NP (NP (DT the) (NNP Tokyo) (NNP Metropolitan) (NNP Institute)) (PP (IN of) (NP (NNP Medical) (NNP Science)))))) (, ,)) (VP (VBD said) (NP (DT the) (NN antibody)) (SBAR (S (NP (PRP he)) (VP (VBD discovered) (NP (NNS works)) (PP (IN by) (S (VP (VBG recognizing) (NP (NP (DT an) (NN antigen)) (VP (VBN called) (S (NP (DT a) (NNP Fas) (HYPH -) (NNP antigen)))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ characteristic) (PP (IN of) (NP (DT an) (JJ infected) (NN cell))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10007" span="word_169..word_175" tag="(S1 (S (NP (DT The) (NN antibody)) (ADVP (RB then)) (VP (VBZ kills) (NP (DT the) (NN cell))) (. .)))" mmax_level="parse" />
<markable id="markable_10008" span="word_176..word_210" tag="(S1 (S (NP (NP (NNP Dr.) (NNP Yonehara)) (CC and) (NP (NP (PRP$ his) (NN partner)) (, ,) (NP (NP (NNP Nobuyuki) (NNP Kobayashi)) (PP (IN of) (NP (NNP Yamaguchi) (NNP University)))) (, ,))) (VP (VBD said) (SBAR (S (NP (PRP$ their) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NN antibody)) (VP (VBD wiped) (PRT (RP out)) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (ADJP (NNP AIDS) (HYPH -) (VBN infected)) (NNS cells)))))) (PP (IN within) (NP (CD three) (NNS days)))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10009" span="word_211..word_228" tag="(S1 (S (S (PP (IN In) (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NNS experiments))))) (, ,) (NP (PRP it)) (VP (VBD killed) (NP (RB almost) (PDT all) (DT the) (JJ infected) (NNS cells)))) (, ,) (NP (DT the) (NNS researchers)) (VP (VBD said)) (. .)))" mmax_level="parse" />
<markable id="markable_10010" span="word_229..word_241" tag="(S1 (S (ADVP (RB Meanwhile)) (, ,) (NP (NP (QP (JJR fewer) (IN than) (CD 10)) (NN %)) (PP (IN of) (NP (DT the) (JJ healthy) (NNS cells)))) (VP (VBD were) (VP (VBN killed))) (. .)))" mmax_level="parse" />
<markable id="markable_10011" span="word_242..word_257" tag="(S1 (S (NP (DT The) (CD two)) (VP (VBD said) (SBAR (S (NP (PRP they)) (VP (MD must) (ADVP (RB still)) (VP (VP (VB do) (NP (JJR more) (NN laboratory) (NNS tests))) (, ,) (ADVP (RB then)) (VP (VB experiment) (PP (IN on) (NP (NNS animals))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10012" span="word_258..word_275" tag="(S1 (S (NP (PRP They)) (VP (VBD said) (SBAR (S (NP (PRP they)) (VP (VBD hoped) (S (VP (TO to) (VP (VB conduct) (NP (NP (NNS tests)) (PP (IN on) (NP (NP (JJ human) (NNS patients)) (PP (IN in) (NP (DT the) (NNP U.S.)))))) (PP (IN by) (NP (ADVP (RB late)) (JJ next) (NN year)))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10013" span="word_276..word_293" tag="(S1 (S (S (NP (NNP Japan)) (VP (VBZ does) (RB n't) (VP (VB have) (S (NP (JJ enough) (NNP AIDS) (NNS patients)) (VP (TO to) (VP (VB do) (NP (NP (JJ significant) (NN experimentation)) (PP (IN in) (NP (DT that) (NN country)))))))))) (, ,) (NP (PRP they)) (VP (VBD said)) (. .)))" mmax_level="parse" />
<markable id="markable_10014" span="word_294..word_311" tag="(S1 (S (NP (DT The) (NN announcement)) (VP (VP (VBD got) (NP (NP (JJ wide) (NN exposure)) (PP (IN in) (NP (DT the) (JJ Japanese) (NNS media))))) (, ,) (CC and) (ADVP (RB even)) (VP (VBD moved) (NP (DT some) (JJ pharmaceutical) (NNS stocks)) (NP (NN yesterday)))) (. .)))" mmax_level="parse" />
<markable id="markable_10015" span="word_312..word_355" tag="(S1 (S (CC But) (NP (NP (NNP Takashi) (NNP Kitamura)) (, ,) (NP (NP (NP (NN director)) (PP (IN of) (NP (NP (DT the) (NN biology) (NN department)) (PP (IN at) (NP (NP (NP (NNP Japan) (POS 's)) (NNP National) (NNP Institute)) (PP (IN of) (NP (NNP Health)))))))) (CC and) (NP (NP (NN secretary)) (PP (IN of) (NP (NP (DT the) (NN government) (POS 's)) (NML (NNP AIDS) (HYPH -) (NN research)) (NN center))))) (, ,)) (VP (VBD said) (, ,) (`` ``) (S (NP (PRP I)) (VP (VBP 'm) (RB not) (ADJP (RB so) (JJ optimistic) (PP (IN of) (NP (NP (PRP$ its) (JJ future) (NN use)) (PP (IN in) (NP (JJ therapeutic) (NNS methods))))))))) (. .) ('' '')))" mmax_level="parse" />
<markable id="markable_10016" span="word_356..word_379" tag="(S1 (S (NP (PRP He)) (VP (VP (VBD said) (SBAR (S (NP (DT some) (JJ infected) (NNS cells)) (VP (MD may) (RB not) (VP (VB have) (NP (DT the) (JJ relevant) (NN antigen))))))) (CC and) (ADVP (RB so)) (VP (MD would) (RB n't) (VP (VB be) (VP (VBN killed) (PP (ADVP (RB even)) (IN after) (NP (NP (NN exposure)) (PP (IN to) (NP (DT the) (NN antibody))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10017" span="word_380..word_404" tag="(S1 (SINV (`` ``) (S (NP (DT The) (NNS results)) (VP (VBP seem) (S (VP (TO to) (VP (VB be) (ADJP (RB very) (JJ premature))))))) (, ,) ('' '') (VP (VBD said)) (NP (NP (NNP Mitsuru) (NNP Miyata)) (, ,) (NP (NP (NN editor)) (PP (IN of) (NP (NP (NNP Nikkei) (NN Biotechnology)) (, ,) (NP (DT a) (JJ leading) (JJ Japanese) (NN industry) (NN newsletter)))))) (. .)))" mmax_level="parse" />
<markable id="markable_10018" span="word_405..word_419" tag="(S1 (S (NP (NNP Dr.) (NNP Kobayashi)) (VP (VBD responded) (SBAR (IN that) (S (NP (PRP he)) (VP (VBD thought) (SBAR (S (NP (DT the) (NN antibody)) (VP (MD could) (ADVP (RB potentially)) (VP (VB kill) (NP (DT all) (JJ infected) (NNS cells)))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10019" span="word_420..word_437" tag="(S1 (S (CC But) (NP (NP (PRP he)) (CC and) (NP (NNP Dr.) (NNP Yonehara))) (VP (VBD said) (SBAR (S (NP (EX there)) (VP (VBD were) (ADVP (RB still)) (NP (JJ several) (NNS uncertainties)) (, ,) (PP (ADVP (RB particularly)) (VBG regarding) (NP (JJ possible) (NN side) (NNS effects))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10020" span="word_438..word_463" tag="(S1 (SINV (`` ``) (S (S (NP (PRP$ Our) (NN antibody)) (ADVP (RB specifically)) (VP (VBD killed) (NP (JJ infected) (NNS cells)) (PP (IN at) (NP (DT a) (ADJP (RB very) (JJ low)) (NN dose))))) (, ,) (CC but) (S (NP (PRP it)) (VP (MD can) (ADVP (RB also)) (VP (VB kill) (NP (JJ other) (NNS cells)))))) (, ,) ('' '') (VP (VBD said)) (NP (NNP Dr.) (NNP Yonehara)) (. .)))" mmax_level="parse" />
<markable id="markable_10021" span="word_464..word_479" tag="(S1 (S (`` ``) (NP (PRP We)) (VP (VBP do) (RB n't) (VP (VB know) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (PRP$ our) (NN antibody))) (PP (IN on) (NP (DT the) (JJ human) (NN body)))))) (. .) ('' '')))" mmax_level="parse" />
<markable id="markable_10022" span="word_480..word_522" tag="(S1 (S (S (NP (NNP AIDS)) (VP (VBZ is) (RB n't) (VP (VBN considered) (NP (DT a) (JJ widespread) (NN problem)) (PP (IN in) (NP (NNP Japan)))))) (PRN (: --) (S (NP (DT the) (NN government)) (VP (VBZ reports) (PP (IN about) (NP (NP (CD 1,000) (JJ known) (NNS carriers)) (PP (IN of) (NP (DT the) (NN virus))))))) (: --)) (CC but) (S (NP (JJ many) (NNS companies)) (VP (VBP have) (VP (VBN poured) (NP (JJ substantial) (NNS resources)) (PP (IN into) (NP (NN research))) (PP (IN in) (NP (JJ recent) (NNS years))) (, ,) (S (VP (VBG hoping) (S (VP (TO to) (VP (VB cash) (PRT (RP in)) (PP (IN on) (NP (DT a) (JJ possible) (NN cure))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10023" span="word_523..word_556" tag="(S1 (S (NP (NNP Dr.) (NNP Kitamura)) (VP (VBD said) (SBAR (SBAR (S (NP (QP (IN about) (CD 35)) (NNS projects)) (VP (VBP are) (ADVP (RB currently)) (PP (IN under) (NP (NN way))) (PP (IN in) (NP (NNP Japan)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (JJ Japanese) (NNS researchers)) (PP (IN in) (NP (DT the) (JJ past) (NN year)))) (VP (VBP have) (VP (VBN made) (S (ADJP (JJ available) (NP (NP (CD three) (JJ possible) (NNS cures)) (PP (IN to) (NP (JJ American) (NNS researchers)))) (PP (IN for) (NP (JJ clinical) (NNS tests))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10024" span="word_557..word_586" tag="(S1 (S (NP (PRP He)) (VP (VBD said) (SBAR (IN that) (S (SBAR (WHADVP (WRB when)) (S (NP (NP (NNS scientists)) (PP (IN from) (NP (DT the) (CD two) (NNS countries)))) (VP (VBP meet) (PP (ADVP (RB again)) (IN in) (NP (NNP January))) (PP (IN in) (NP (NNP New) (NNP Orleans)))))) (, ,) (NP (DT the) (NNPS Japanese)) (VP (MD will) (VP (VB present) (NP (QP (ADVP (RB at) (RBS least)) (CD three) (JJR more)) (NNS drugs)) (PP (IN for) (NP (JJ human) (NN testing)))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10025" span="word_587..word_600" tag="(S1 (S (NP (NNP AZT)) (VP (VBZ is) (NP (NP (NP (DT the) (NN world) (POS 's)) (JJ only) (NN prescription) (NN medicine)) (VP (VBN approved) (PP (IN for) (S (VP (VBG treating) (NP (DT the) (NN disease)))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10026" span="word_601..word_617" tag="(S1 (S (NP (NP (NNP Wellcome) (NNP PLC)) (, ,) (NP (DT a) (JJ major) (JJ British) (NN pharmaceutical) (NN maker)) (, ,)) (VP (VBZ sells) (NP (DT the) (NN drug)) (PP (IN under) (NP (NP (DT the) (NN name)) (NP (NNP Retrovir))))) (. .)))" mmax_level="parse" />
<markable id="markable_10027" span="word_618..word_632" tag="(S1 (S (NP (DT A) (NNP Wellcome) (NN spokesman)) (VP (VBD declined) (S (VP (TO to) (VP (VB comment) (PP (IN on) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (DT the) (NN antibody))) (PP (IN in) (NP (NNP Japan))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10028" span="word_633..word_673" tag="(S1 (S (CC But) (NP (NP (NNP Andrew) (NNP Porter)) (, ,) (NP (NP (DT a) (NML (NN drug) (HYPH -) (NN industry)) (NN analyst)) (PP (IN at) (NP (NP (NNP Nikko) (NNPS Securities) (NNP Co.)) (PP (IN in) (NP (NNP London)))))) (, ,)) (VP (VBD said) (SBAR (IN if) (S (NP (DT the) (NN product)) (VP (VBD were) (S (VP (TO to) (VP (VB be) (ADVP (RB successfully)) (VP (VBN developed) (SBAR (S (NP (PRP it)) (VP (MD would) (VP (VB represent) (`` ``) (NP (NP (DT a) (JJ potential) (NN threat)) (PP (IN to) (NP (NP (DT the) (NML (JJ long) (HYPH -) (NN term)) (NN viability)) (PP (IN of) (NP (NNP Retrovir)))))))))))))))))) (. .)))" mmax_level="parse" />
</markables>
